Nurmohamed M, Choy E, Charles-Schoeman C, et al. Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials. ACR 2017, abstract 2966.
Associatie miR200b-5p-expressie en non-hodgkinlymfoom bij Sjögren
okt 2018 | Sjögren